These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 324637)

  • 1. Effector cells for antibody-dependent cell mediated cytotoxicity. I. Increased cytotoxicity after priming with BCG-SS.
    Pollack SB
    Cell Immunol; 1977 Mar; 29(2):373-81. PubMed ID: 324637
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytotoxicity in vitro by products of specifically stimulated spleen cells: susceptibility of tumor cells and normal cells.
    Meltzer MS; Bartlett GL
    J Natl Cancer Inst; 1972 Nov; 49(5):1439-43. PubMed ID: 4568090
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunoadjuvant treatment of primary grafted and spontaneous AKR-leukemia. II. In vitro cytotoxicity of lymphoid cells against normal and malignant syngeneic cells and against normal allogeneic cells.
    Olsson L; Ebbesen P
    J Immunol; 1979 Mar; 122(3):781-6. PubMed ID: 376706
    [No Abstract]   [Full Text] [Related]  

  • 4. Effector cells which mediate antibody-dependent cell-mediated cytotoxicity. II. Ontogeny of effector activity in murine spleen.
    Pollack SB; Kraft DS
    Cell Immunol; 1977 Nov; 34(1):1-9. PubMed ID: 334381
    [No Abstract]   [Full Text] [Related]  

  • 5. Lymphocyte-macrophage interactions in BCG-treated mice.
    Florentin I; Bruley-Rosset M; Davigny M
    Recent Results Cancer Res; 1976; (56):49-57. PubMed ID: 794959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms by which tumors avoid destruction by the immune system BCG-catalyzed increase in IgG and IgA blocking activity of lymphocyte-mediated cytotoxicity.
    Hakim AA
    Klin Wochenschr; 1975 Sep; 53(18):881-3. PubMed ID: 1100900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BCG-induced murine effector cells. I. Cytolytic activity in peritoneal exudates: an early response to BCG.
    Tracey DE; Wolfe SA; Durdik JM; Henney CS
    J Immunol; 1977 Sep; 119(3):1145-51. PubMed ID: 330748
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro immunisation against human tumour cells with bacterial extracts.
    Sharma B; Tubergen DG; Minden P; Brunda MJ
    Nature; 1977 Jun; 267(5614):845-7. PubMed ID: 408706
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of in vitro cytotoxic responses by BCG-induced macrophage-like suppressor cells. II. Suppression occurs at the level of a "helper" T cell.
    Klimpel GR; Okada M; Henney CS
    J Immunol; 1979 Jul; 123(1):350-7. PubMed ID: 156233
    [No Abstract]   [Full Text] [Related]  

  • 10. Modification of the migration of mouse lymphoid cells by BCG: a factor stimulating T-cell migration.
    Castes M; Borderie N; Orbach-Arbouys S
    Cell Immunol; 1978 Sep; 40(1):37-45. PubMed ID: 359172
    [No Abstract]   [Full Text] [Related]  

  • 11. Influence of immunisation with Mycobacterium bovis bacillus Calmette-Guérin on the sensitisation to inhaled allergens after infection with respiratory syncytial virus.
    Vonberg RP; Mueller M; Emmendoerffer A; Freihorst J
    Clin Exp Med; 2005 Dec; 5(4):177-83. PubMed ID: 16362797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cell-wall skeleton of Mycobacterium bovis BCG on cell-mediated cytotoxicity in tumor-bearing mice.
    Taniyama T; Azuma I; Aladin AA; Yamamura Y
    Gan; 1975 Dec; 66(6):705-9. PubMed ID: 817955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural cytotoxic cells against solid tumors in mice. II. Some characteristics of the effector cells.
    Paige CJ; Figarella EF; Cuttito MJ; Cahan A; Stutman O
    J Immunol; 1978 Nov; 121(5):1827-35. PubMed ID: 361891
    [No Abstract]   [Full Text] [Related]  

  • 14. Malignant melanoma: specific immunity induced by bacillus Calmette-Guérin in BALB-c mice.
    Faraci RP; Schour L
    Science; 1974 Jul; 185(4145):68-9. PubMed ID: 4599426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro assay of cell-mediated immunity in BCG therapy of malignant melanoma: a preliminary report.
    Nathanson L; Clark DA
    Natl Cancer Inst Monogr; 1973 Dec; 39():221-4. PubMed ID: 4595321
    [No Abstract]   [Full Text] [Related]  

  • 16. Activation of mouse peritoneal cells to kill Listeria monocytogenes by T-lymphocyte products.
    Cole P
    Infect Immun; 1975 Jul; 12(1):36-41. PubMed ID: 806534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological intervention in neoplasia.
    Weiss DW
    Johns Hopkins Med J Suppl; 1974; 3():131-56. PubMed ID: 4371312
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of BCG on lymphocyte trapping.
    Zatz MM
    J Immunol; 1976 Jun; 116(6):1587-91. PubMed ID: 774988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on the cytotoxicity of spleen lymphocytes and immune mechanisms in mice immunized by Mycobacterium tuberculosis H37Ra].
    Wang LX; Lu XY; Li H; Yang Q
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Feb; 23(2):164-7. PubMed ID: 17286912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introduction of "natural" killer' cells by BCG.
    Wolfe SA; Tracey DE; Henney CS
    Nature; 1976 Aug; 262(5569):584-6. PubMed ID: 785281
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.